NeurOptics

NeurOptics, Inc. is a medical device company based in Irvine, California, specializing in pupillometry, which involves measuring pupil size and reactivity. The company is a leader in this field, dedicated to enhancing patient outcomes through innovative technology. NeurOptics develops advanced pupillometry devices, including their flagship product, the NPi Pupillometer. This device provides objective data on neurological function, aiding clinicians in making informed medical decisions. Their products are utilized in critical care medicine, neurology, neurosurgery, emergency medicine, and clinical research. NeurOptics' pupillometers are Class 1 medical devices, manufactured in compliance with international quality standards. The company serves a diverse customer base, including hospitals and research institutions across over 40 countries. NeurOptics is led by experienced professionals, including founder Kamran Siminou and President and CEO Bill Worthen, who bring extensive expertise in the medical device industry. NeurOptics is committed to quality, innovation, and making a global clinical impact.

• Employees 78
• Founded 1995
• Annual Revenue $30974000
• Total Funding $2246627